Olaparib beim metastasierten, kastrationsresistenten Prostatakarzinom
- PMID: 35345006
- DOI: 10.1055/a-1562-3862
Olaparib beim metastasierten, kastrationsresistenten Prostatakarzinom
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.N Engl J Med. 2020 Dec 10;383(24):2345-2357. doi: 10.1056/NEJMoa2022485. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955174 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources